The properties of enteroviruses justify their consideration as possible causes of foetal damage: they are highly prevalent and cause infections which, although usually of minor severity, are often associated with viraemia. Of the enteroviruses, ECHO type 9 is of particular interest because of its periodic epidemic prevalence and the similarity to rubella of many of the infections it causes. Studies by Rantasalo, Penttinen, Saxen, and Ojala (1960) and by Kleinman, Prince, Mathey, Rosenfield, Bearman, and Syverton (1962) did not reveal unequivocal evidence of association between ECHO 9 virus infection during pregnancy and malformation of the infant born subsequently. The possibility that this infection may not cause foetal damage is also of importance to the clinician assessing the implications of a rubelliform illness during pregnancy, and to the epidemiologist evaluating the risk of congenital abnormality complicating "rubella" in studies in which an unknown proportion of maternal illnesses might have been due to ECHO 9 infection with fever, rash, and lymph-node enlargement. An epidemic of ECHO 9 infection in Glasgow in 1960 (Landsman and Bell, 1962; Combined Scottish Study, 1964) (1) They were insufficient in quantity or were anticomplementary and so were unsuitable for ECHO 9 antibody tests (350);
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(2) The outcome of pregnancy could not be traced because of change of address, or because the mother lived in areas beyond the city boundary, etc. (78); (3) Diagnosis of pregnancy not sustained (13).
RECORDS
Women were traced by means of laboratory specimen numbers, using a pre-arranged code which indicated the clinic attended. Ante-natal records were examined on the clinic premises and the desired information was transcribed onto punch cards. These records were those used in the normal conduct of the clinics. Questions regarding illness during pregnancy were not specifically directed towards possible ECHO 9 infection. None of the women was interviewed by us.
Among the details entered on punch cards were the mother's age and parity, the date on which serum was obtained, and the duration of pregnancy at that date (calcuilated in weeks from the date of onset of the last menstrual period). For 
LABORATORY METHODS
Examination for ECHO 9 antibodies was carried out by complement-fixation (CF) technique, using an antigen prepared from human amnion tissue culture infected with a current epidemic strain of ECHO 9 virus; the details of the method have been described elsewhere (Bell, Stott, and Ross, 1964) . The serological titres for ECHO 9 antibodies were expressed as reciprocals; a titre of 1 : 128 or greater was regarded as indicative of recent infection (Bell and others, 1964) , and titres of 1: 32 or 1: 64 as presumptive evidence of recent infection. Between October, 1960, and February, 1961 , single specimens of serum were obtained from 2,631 pregnant women. Of these pregnancies, 41 resulted in abortion, 48 in a stillbirth (11 with a congenital defect), and 2,542 in a live birth (45 with a congenital defect). Table I shows the distribution of the 2,631 pregnancies by month of conception correlated with evidence of the activity of ECHO 9 virus in Glasgow shown by 77 isolations of this virus from patients, mostly with aseptic meningitis or febrile exanthem.
RESULTS
It can be seen that almost all of the women had a possibility of exposure to ECHO 9 virus during the early months of pregnancy. ECHO 9 CF antibody titres of 1: 128 or more were found in 31 (1 -2 per cent.) and titres of 1: 32 to 1: 64 in 256 (9 8 per cent.). However, it was not possible to determine from the available evidence whether the infections occurred during or before pregnancy. CONGENITAL DEFECTS.-56 were reported, of which 47 were recognized at birth and nine by the time of follow-up at one year. Table II shows the outcome of pregnancy in relation to the titre of ECHO 9 antibody. The proportion of pregnancies resulting in a congenital defect was the same (2 1 per cent.) among mothers with significant titres of antibody as among those without such antibody. Abortions occurred with similar frequency in those with and those without significant titres. Thus no evidence was obtained that recent ECHO 9 infection was associated with increased foetal loss or damage. Comparison of the normal with the congenitally defective group, taking into consideration the duration of pregnancy at which the examination for antibodies was made, provides the figures shown in Table III . In 67 of the 592 pregnancies in which antibody estimations were made within the first 16 weeks, a titre of ECHO 9 antibody of 1: 32 or more was recorded. Two malformed infants were found in this group of 67, an incidence of 3 per cent. The 1,998 pregnancies of 17 weeks' duration or more at the time of examination included 214 in which the antibody titre was at least 1:32. Four malformed infants were identified, an incidence of 1 '9 per cent. (Bell and others, 1964) . In addition, CF tests are much less expensive in time and materials than neutralization tests, and are therefore more practical for large-scale surveys such as the present. The main disadvantage of CF tests for ECHO 9 infection is that infections with other enteroviruses may give rise to heterotypic CF cross-reactions to ECHO 9 (Tyrrell, Clarke, Heath, and Curran, 1958; Johnsson, Bottiger, and Lofdahl, 1958; Wigand and Sabin, 1962) . However, during the period of our study, ECHO 9 was the only epidemic enterovirus in the community and therefore it seemed reasonable to accept high antibody titres as presumptive evidence of recent infection with this virus. The highest titre associated with congenital abnormalities in our study was 1: 32. Although lower than the titres usually found after overt illness associated with ECHO 9 virus infection (Bell and others, 1964) , this level was selected to divide the mothers into two groups for comparison. Our investigation, like that of Rantasalo and others (1960) , shows no correlation between congenital malformations and presumptive serological evidence of ECHO 9 virus infection of mothers during pregnancy. The findings of Kleinman and others (1962) were similar, except for a suggestive association of skin abnormalities with ECHO 9 virus infection. The City of Glasgow's statistics also showed no significant increase of congenital malformations after the ECHO 9 epidemic of 1960, but ECHO 9 virus may not be more likely to cause foetal damage than other enteroviruses prevalent in other years.
It is possible that some congenital malformations were not recorded in the reports at our disposal, that some were missed because only a sample of infants was followed up at one year, and that others did not become apparent until later. It seems unlikely, however, that anencephalus would not be recorded, since this is an easily recognized malformation and notifications should therefore be accurate. Record (1961) , using the Scottish statistics, showed that the contribution of anencephalus to stillbirths increased from 5 * 8 to 12 * 7 per cent. between 1938-41 and 1956-58, despite a Since the neurotropic properties of ECHO 9 virus are well established, its investigation as a possible teratogenic agent in regard to anencephalus was fully justified. In the present study twelve anencephalic births were registered, giving a rate of 24 -5 per cent. among the 49 stillbirths. This is higher than the figure for the later years of Record's analysis but less than half the rate (58 per cent.) reported by Kleinman and his colleagues.
The negative nature of our report confirms the conclusions of others that, if ECHO 9 is a teratogenic agent, it is not markedly so. However, other viruses may yet be incriminated by observations whenever their epidemic prevalence is recognized. The introduction by the Ministry of Health (1963) of a scheme for notifying congenital malformations will be of great assistance to future investigations of this important problem.
SUMMARY
Single specimens of serum from 2,631 women who became pregnant during an epidemic of ECHO type 9 virus infection were examined for complementfixing antibody to the virus.
The proportion of pregnancies resulting in a congenital defect was the same (2*1 per cent.) among the 287 women with significant titres of antibody as among those (2,344) without such antibody.
Pregnancies in which infection was shown to have occurred before the end of the 16th week were not associated with a higher rate of congenital defects.
56 congenital malformations were recorded at birth or at follow-up of a sample of the children at one year. Three of the 56 mothers had significant titres of antibody and one of these was the only mother of a malformed child to give a history of febrile illness in early pregnancy.
The study failed to show any correlation between congenital malformations and presumptive serological evidence of ECHO 9 virus infection of mothers during pregnancy.
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